Mind Boggling: Dementia Diagnoses & Evolving Demographic Trends
October 26, 2022
We all know that as a society, our population is getting older and living longer than previous generations. And while that’s a wonderful trend if you are able to get more years of good health and quality living, the flipside of that is many of us will face, either for…
Next Up: Another (More Promising?) New Drug For Alzheimer’s
October 5, 2022
You may remember that more than a year ago, we posted a story on the arrival of a new drug approved by the FDA for the treatment of Alzheimer’s disease. That drug is Aduhelm, and while it is technically on the market and available, its use has been greatly limited…
It Doesn’t Take Much: Lifestyle Tweaks To Sustain Your Brain
August 10, 2022
With continued disappointing news about forthcoming drugs to address Alzheimer’s, you might begin to despair that there’s little you can do to prevent an Alzheimer’s or dementia diagnosis and that you may as well throw up your arms in distress. However, as we’ve pointed out in previous posts, there are…
Red, Right, And Blue: Eating Berries May Lower Your Risk Of Dementia
May 25, 2022
While we have no choice but to wait for medications or interventions that can cure dementia, we are not without weapons in our arsenal to reduce the risk of this scourge. As we’ve previously reiterated, there are a host of lifestyle interventions that may not cure dementia but are known…
Do You Recall? Mild Cognitive Impairment And Other Memory Concerns
March 24, 2022
As you may recall (or perhaps you don’t!) about a year ago we published a post on memory loss, addressing the condition known as Mild Cognitive Impairment (MCI), which can cause memory lapses that constitute more than what you should expect from “normal aging” but less than the impairment that…
State Of Play: What’s Going On With Alzheimer’s Treatments?
November 10, 2021
So it’s been several months since the new Alzheimer’s drug Aduhelm was introduced, in a hopeful sign that a treatment for Alzheimer’s might finally be available. As you may recall, in June we reported on the FDA approval of Aduhelm, a medication that targets the build-up of amyloid plaques in…